Publication: 2046

A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer
      QxMD      Google Scholar   
Citation:
J Thorac Oncol vol 9 (2) 214-221
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
3
Parents:
362  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA032291, CA33601, CA032291, U10 CA071323, CA77597, CA11789, U10 CA077658, CA77406, CA047559, CA32291, U10 CA086726, CA29165, U10 CA045564, CA41287, U10 CA045808, U10 CA031946, U10 CA033601, U10 CA077597, CA45808, U10 CA114558, CA12046, U10 CA045418, CA86726, CA16450, U10 CA041287, CA45564, U10 CA047559, CA21060, P30 CA016058, CA47559, CA114558-02, CA47642, CA71323, CA45418, CA77658, CA77298, CA114558, U10 CA047642, CA31946  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
CALGB-30704
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
CALGB 30704, Lung cancer